A Forward Look, The Year Ahead - Research Report on WellPoint, Inc., E I Du Pont De Nemours And Co., The Dow Chemical Company, Dover Corp and Rexnord Corp

Thu Mar 14, 2013 8:01am EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130314:nPn3137071


NEW YORK,  March 14, 2013  /PRNewswire/ --

Today, Investors Alliance announced new research reports highlighting WellPoint,
Inc. (NYSE:WLP), E I Du Pont De Nemours And Co. (NYSE:DD), The Dow Chemical
Company (NYSE:DOW), Dover Corp (NYSE:DOV) and Rexnord Corp (NYSE:RXN). Today's
readers may access these reports free of charge - including full price targets,
industry analysis and analyst ratings - via the links below.

WellPoint, Inc. Research Report

Wellpoint logged revenue of  $15.27 billion  in its latest earnings report,
enough to meet the expectations of S&P Capital IQ. Earnings per share came in at
 $1.03, while gross, operating, and net margins increased 20.4 percent, 4.1
percent, and 3 percent, respectively. The company is fresh from its selection of
new CEO  Joseph Swedish, who will start on  March 25. The former President of
Trinity Health will succeed  Angela Braly, who resigned last year after posting
subpar results. The new CEO helped grow Trinity's revenues by 50 percent in
seven years, while doubling operating profit margins. The Street puts Wellpoint
as a "buy," citing the performance of its net income, revenue growth, financial
position with reasonable debt levels, valuation levels and cash flow from
operations. The Full Research Report on WellPoint, Inc. - including full
detailed breakdown, analyst ratings and price targets - is available to download
free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/dcf6_WLP]

--

E I Du Pont De Nemours And Co. Research Report

Du Pont, which also has operations in agriculture, electronics, among others
aside from chemicals, has been upgraded to a "neutral" by Zacks after posting
better-than-expected results in Q4 2012 with net sales of  $7.3 billion 
compared to the estimated  $7.25 billion, though is flat year-over-year.
However, good cash flow from operations and notable return on equity should
outweigh the underperforming net income numbers. Du Pont is the world's largest
manufacturer of titanium dioxide, a white pigment used in paint. The product
should help the company's performance chemicals unit stable throughout Q1 as
excess inventories are used up and demand dries up. However, Du Pont's other
chemical units are slowly being sold off to other companies. The company is on
the verge of selling its cyanide business, which could fetch as much as  $700
million  and is projected to have net earnings of around  $100 million. This is
part of the company's transition to a more food and agriculture-based business,
with an earlier sale of its car paint unit to the Carlyle Group in mid-2012..
The Full Research Report on E I Du Pont De Nemours And Co. - including full
detailed breakdown, analyst ratings and price targets - is available to download
free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/0bb1_DD]

--

The Dow Chemical Company Research Report

Dow Chemical is expected to receive a whopping 32% jump in its earnings numbers
despite posting dismal numbers in Q3 and spending a lot for restructuring
programs to cut costs. The stock went up as much as 13 percent, as Motley Fool
reported. The positive gains can be credited to its decision to restart
operations of its ethylene cracker in  Louisiana, which has been idle for four
years. Coincidentally, ethylene raw material ethane has hit a five-year low
around the same time the plant reopened. However, a Motley Fool report says it
won't make a dent on Dow's earnings numbers. However, the restructuring plan is
expected to save Dow an estimated  $500 million  as it cuts close to 2,400 jobs
and 20 plants. It would also be posting a restructuring charge of up to  $1.1
billion  during the last quarter.. The Full Research Report on The Dow Chemical
Company - including full detailed breakdown, analyst ratings and price targets -
is available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/1006_DOW]

--

Dover Corp Research Report

Dover, who has businesses in telecoms, energy, engineered systems, and printing
and identification, beat expectations with its adjusted earnings per share for
Q4 at  $1.09  per share, compared to Zacks' estimate of  $1.07. Revenues
meanwhile came in at  $2 billion  for that quarter, or more than 6 percent year
over year, which met expectations. The stock had been hit recently due to
concerns over its handset business, though some analysts say it might have been
overdone considering Dover's ability to generate cash and its growth record. The
issue lies with underwhelming sales of its major customer Nokia, who is being
supplied with products from its Sound Solutions business. Motley Fool says Dover
does sell to Samsung as well, who is now the largest smartphone manufacturer
worldwide. The only company it does not have a decent market share with is
Apple, who itself has been slowly declining as of late. In addition, the
relatively weak Q4 numbers reflect normal seasonality. The Street rates Dover as
a "buy," citing its performance in revenue growth, debt, stock price, cash flow
from operations, and earnings per share. The Full Research Dover Corp -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/aa96_DOV]

--

Rexnord Corp Research Report

Rexnord saw its shares increase 14, after news of a potential sale surfaced
after initiating a "review of strategic alternatives" with Goldman Sachs serving
as its financial adviser. The sale of one or both its business platforms are
also being considered. Its Q3 results indicated net income of  $9.2 million  or 
9 cents  per share, up from  $5.6 million  or  $0.08  per share year over year.
Income from continuing operations for the third quarter was  $11.4 million  or 
$0.11  per share, compared to  $5.5 million  or  $0.08  per share the same time
the previous year. For Q4, the company forecast sales to be between  $535
million to $555 million, while analysts currently expect the company to post
revenue of  $555.25 million. The Full Research Report on Rexnord Corp -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.Investors-Alliance.com/r/full_research_report/fe8f_RXN]

--

Consider Investors Alliance

Tired of hearing about the latest, greatest trade opportunity... only to realize
that the ship has long sailed? You need a strong, informative community in your
arsenal. Join the group that has been consistently identifying momentous
situations as they develop - long before they become the next top news on major
financial networks.

Contact:  Patricia Byers

Email:  press@Investors-Alliance.com

Main: +1-480-745-7826


SOURCE  Investors-Alliance

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.